My research focuses on the neurocognitive and psychosocial effects of cancer and cancer treatments in survivors of pediatric and adult-onset cancers. Our group examines sociodemographic, disease, and treatment factors associated with better or worse outcomes, and interventions that aim to improve outcomes or alleviate adverse effects in survivors.